Symbolic Representation in Young Children With Down Syndrome

This study has been completed.
Sponsor:
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by:
University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT00668980
First received: April 25, 2008
Last updated: January 13, 2010
Last verified: January 2010

April 25, 2008
January 13, 2010
July 2006
April 2009   (final data collection date for primary outcome measure)
Performance on monthly assessments administered after the initial evaluation [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Performance on monthly assessments administered after the initial evaluation [ Time Frame: 10 months ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00668980 on ClinicalTrials.gov Archive Site
 
Performance on a initial and final assessments, after 10 months of speech-language therapy for SG and CG1. [ Time Frame: 10 months ] [ Designated as safety issue: No ]
 
 
 
Symbolic Representation in Young Children With Down Syndrome
The Constitution of Symbolic Representation in Young Children With Down Syndrome

The aim of this study is to characterize the process of constitution of symbolic representation in infants with Down syndrome, as well as to investigate the relationship between gestures and the emergence of oral language. The investigators hypothesis is that children with Down syndrome could present difficulties during the constitution of symbolic representation that may be related to later deficits on expressive language, generally observed in these children.

According to the Genetic Epistemology, language development is directly related to cognitive construction. Such relationship is clearly observed after the constitution of representation that allows one individual to express his or her thinking through language.

Observational
Observational Model: Case Control
Time Perspective: Prospective
 
Non-Probability Sample

Study Group - children with Down syndrome that attend speech-language therapy at the Speech Language Pathology Laboratory in Syndromes and Sensorimotor Deficits of the School of Medicine of the University of São Paulo or from the Association of Parents and Friends of Exceptional children of São José dos Campos.

Control Group

- typically developing children followed up in the Pediatrics Ambulatory of the University's Hospital and/or being assisted in the University' Hospital Nursery School.

Down Syndrome
 
  • Study group
    20 infants with Down syndrome
  • Control Group
    15 typically developing children
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
25
April 2009
April 2009   (final data collection date for primary outcome measure)

Inclusion Criteria for Study Group:

  • genetic diagnosis of Down Syndrome
  • be at the 4th stage of sensorimotor period at the initial assessment
  • good health conditions
  • good results on audiologic evaluation
  • pediatric and ear, nose and throat periodic check ups.

Inclusion Criteria for Control Group:

  • good health conditions
  • be at the 4th stage of sensorimotor period at the initial assessment
  • pediatric and ear, nose and throat periodic check ups.

Exclusion Criteria for all groups:

  • submission to long term hospitalizations due to heart diseases and major respiratory airway infections, that may interfere in the child's global development
  • presence of visual or auditory important deficits
  • historic of prematurely and/or low birth weight
Both
 
Yes
Contact information is only displayed when the study is recruiting subjects
Brazil
 
NCT00668980
06/50842-4
Yes
Suelly Cecilia Olivan Limongi, University of Sao Paulo
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo
Study Chair: Suelly CO Limongi, PhD. University of Sao Paulo
Principal Investigator: Fabiola C Flabiano, PhD. student University of Sao Paulo
University of Sao Paulo
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP